World's Best Scientists 2026 revealed!
Award Badge
Molecular Biology
USA
2025

D-Index & Metrics

Genetics

D-Index
129
Citations
65585
World Ranking
262
National Ranking
136

Molecular Biology

D-Index
129
Citations
65585
World Ranking
192
National Ranking
120

Mark A. Kay publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Mark A. Kay sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 462 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Mark A. Kay D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Mark A. Kay sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 129 D-Index — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Research.com Recognitions

  • 2025 - Research.com Molecular Biology in United States Leader Award
  • 2023 - Research.com Molecular Biology in United States Leader Award
  • 2020 - Fellow, National Academy of Inventors

Overview

Mark A. Kay is affiliated with Stanford University in the United States. Their research primarily spans the fields of Biochemistry, Genetics, and Molecular Biology, with notable contributions in Medicine as well. Within these domains, their work focuses on subfields such as Molecular Biology, Genetics, Cancer Research, Oncology, and Epidemiology.

The scientist's research topics include:

  • CRISPR and Genetic Engineering
  • Virus-based gene therapy research
  • RNA modifications and cancer
  • RNA and protein synthesis mechanisms
  • RNA Interference and Gene Delivery
  • CAR-T cell therapy research
  • Cancer-related molecular mechanisms research

Mark A. Kay's most frequent publication venues are:

  • Molecular Therapy
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Molecular Therapy - Methods & Clinical Development
  • UNC Libraries

Frequent co-authors include:

  • Katja Pekrun
  • Feijie Zhang
  • Hak Kyun Kim
  • Jianpeng Xu
  • Francesco Puzzo

Notable recent papers authored or co-authored by Mark A. Kay are:

  • Novel NanoLuc substrates enable bright two-population bioluminescence imaging in animals, 2020, Nature Methods
  • Evaluating the state of the science for adeno-associated virus integration: An integrated perspective, 2022, Molecular Therapy
  • Transfer RNA-Derived Small RNAs: Another Layer of Gene Regulation and Novel Targets for Disease Therapeutics, 2020, Molecular Therapy
  • A standardized ontology for naming tRNA-derived RNAs based on molecular origin, 2023, Nature Methods
  • RNA structure probing reveals the structural basis of Dicer binding and cleavage, 2021, Nature Communications

Mark A. Kay has been recognized with the award of Fellow, National Academy of Inventors in 2020.

Best Publications

  • Progress and problems with the use of viral vectors for gene therapy

    Clare E. Thomas;Anja Ehrhardt;Mark A. Kay

  • Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

    Manno Cs;Pierce Gf;Arruda Vr;Glader B

  • Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B

    Amit C. Nathwani;Edward G.D. Tuddenham;Savita Rangarajan;Cecilia Rosales

  • Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways.

    Dirk Grimm;Konrad L. Streetz;Konrad L. Streetz;Catherine L. Jopling;Theresa A. Storm

  • Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics

    Mark A. Kay;Joseph C Glorioso;Luigi Naldini

  • RNA interference in adult mice.

    Anton P. McCaffrey;Leonard Meuse;Thu-Thao T. Pham;Douglas S. Conklin

  • Long-term safety and efficacy of factor IX gene therapy in hemophilia B

    Amit C Nathwani;Ulreke M Reiss;Edward G D Tuddenham;Cecilia Rosales;Cecilia Rosales

  • Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector

    Mark A. Kay;Catherine S. Manno;Catherine S. Manno;Margaret V. Ragni;Peter J. Larson;Peter J. Larson

  • Inhibition of hepatitis B virus in mice by RNA interference.

    Anton P McCaffrey;Hiroyuki Nakai;Kusum Pandey;Zan Huang

  • A nonviral minicircle vector for deriving human iPS cells

    Fangjun Jia;Kitchener D Wilson;Ning Sun;Deepak M Gupta

  • AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.

    Catherine S. Manno;Amy J. Chew;Sylvia Hutchison;Peter J. Larson

  • Robust expansion of human hepatocytes in Fah −/− / Rag2 −/− / Il2rg −/− mice

    Hisaya Azuma;Nicole Paulk;Aarati Ranade;Craig Dorrell

  • Sarcoma derived from cultured mesenchymal stem cells

    Jakub Tolar;Alma J. Nauta;Mark J. Osborn;Angela Panoskaltsis Mortari

  • State-of-the-art gene-based therapies: the road ahead.

    Mark A. Kay

  • In Vitro and In Vivo Gene Therapy Vector Evolution via Multispecies Interbreeding and Retargeting of Adeno-Associated Viruses

    Dirk Grimm;Joyce S. Lee;Lora Wang;Tushar Desai

  • In vivo activity of nuclease-resistant siRNAs.

    Juliana M. Layzer;Anton P. Mccaffrey;Alice K. Tanner;Zan Huang

  • Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors

    R O Snyder;C H Miao;G A Patijn;S K Spratt

  • Human tRNA-derived small RNAs in the global regulation of RNA silencing

    Dirk Haussecker;Yong Huang;Ashley Lau;Poornima Parameswaran

  • Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8

    Katsuya Inagaki;Sally Fuess;Theresa A. Storm;Gregory A. Gibson

  • Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors

    Richard O. Snyder;Carol Miao;Leonard Meuse;Julie Tubb

Frequent Co-Authors

Dirk Grimm
Dirk Grimm Heidelberg University
André Lieber
André Lieber University of Washington
Katherine A. High
Katherine A. High Children's Hospital of Philadelphia
Markus Grompe
Markus Grompe Oregon Health & Science University
Andrew Fire
Andrew Fire Stanford University
Milton J. Finegold
Milton J. Finegold Baylor College of Medicine
Joseph C. Wu
Joseph C. Wu Stanford University
Savio L. C. Woo
Savio L. C. Woo Icahn School of Medicine at Mount Sinai
Robert C. Robbins
Robert C. Robbins Stanford University
Jakub Tolar
Jakub Tolar University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Molecular Biology in the USA opens doors to diverse and dynamic career opportunities in both research and healthcare sectors. For professionals seeking to expand their expertise or transition into clinical roles, online degree options can provide flexible and accelerated pathways.

Many students interested in applying biological science knowledge to patient care may consider nursing. Programs such as the best online bsn programs for non nurses allow science graduates to pivot into nursing efficiently, making use of their prior academic credits.

Those who hold an RN license and want to advance further can explore a 6-month rn to bsn program, designed for rapid upskilling. These online options not only save time but can also reduce overall education costs.

For scientists interested in advanced clinical practice, learning how to become a np (Nurse Practitioner) is valuable. This route empowers graduates to assess, diagnose, and manage patient health.

Molecular biology knowledge is especially useful in specialized fields, such as psychiatric care. Salaries in these professions are promising; you can see compensation trends by visiting the psych np salary page.

Best Scientists Citing Mark A. Kay

Trending Scientists

Recently Published Articles